M&A Deal Summary

Harvard Bioscience Acquires Data Sciences International

On January 22, 2018, Harvard Bioscience acquired life science company Data Sciences International from Polaris Partners for 70M USD

Acquisition Highlights
  • This is Harvard Bioscience’s 1st transaction in the Life Science sector.
  • This is Harvard Bioscience’s largest (disclosed) transaction.
  • This is Harvard Bioscience’s 2nd transaction in the United States.
  • This is Harvard Bioscience’s 1st transaction in Minnesota.

M&A Deal Summary
Date 2018-01-22
Target Data Sciences International
Sector Life Science
Buyer(s) Harvard Bioscience
Sellers(s) Polaris Partners
Deal Type Add-on Acquisition
Deal Value 70M USD

Target

Data Sciences International

St. Paul, Minnesota, United States
Data Sciences International, Inc. is a provider of acute and chronic physiological monitoring solutions used by scientists for conducting non clinical biomedical research. Data Sciences International, Inc. was established in 1984 and is based in St. Paul, Minnesota.

Search 198,242 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Harvard Bioscience

Holliston, Massachusetts, United States
Category Company
Founded 1901
Sector Medical Products
Employees391
Revenue 112M USD (2023)
DESCRIPTION

Harvard Bioscience is a developer, manufacturer, and marketer of a broad range of apparatus and instruments used in research laboratories at pharmaceutical and bioscience companies, universities, and governmental organizations worldwide. Harvard Bioscience was founded in 1901 and is based in Holliston, Massachusetts.

DEAL STATS #
Overall 3 of 3
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 3 of 3
State (Minnesota) 1 of 1
Country (United States) 2 of 2
Year (2018) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-22 Denville Scientific

Holliston, Massachusetts, United States

Denville Scientific, Inc. is a life science research consumables distributor. Denville Scientific, Inc. was established in 1979 and is based in Holliston, Massachusetts.

Sell $20M

Seller(S) 1

SELLER

Polaris Partners

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1996
PE ASSETS 5.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.

DEAL STATS #
Overall 16 of 32
Sector (Life Science) 3 of 7
Type (Add-on Acquisition) 6 of 14
State (Minnesota) 1 of 1
Country (United States) 14 of 30
Year (2018) 1 of 6
Size (of disclosed) 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-01 Amunix

South San Francisco, California, United States

Amunix is an immuno-oncology company focused on designing and developing masked T cell engagers and cytokines to bring the promise of these potent immune-activating biotherapeutics to patients with cancers. Amunix is headquartered in South San Francisco, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-03-01 Athletes Performance

Phoenix, Arizona, United States

Athletes' Performance, Inc. is a provider of integrated performance training, nutrition and physical therapy for elite athletes, military and corporations.

Sell -
Mergr

Product

Company

Legal